SCHEMBL9872273

SCHEMBL9872273

c1cnc2c(c1)ccc1ncncc12

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.65
CCR1 P32246 3/20 0.52
CCR5 P51681 3/20 0.52
CCR8 P51685 3/20 0.52
KDM4E B2RXH2 3/20 0.52
MAPT P10636 3/20 0.52
CYP3A4 P08684 2/20 0.52
MMP2 P08253 2/20 0.52
TSHR P16473 2/20 0.52
HSP90AA1 P07900 2/20 0.52
GMNN O75496 1/20 0.52
TP53 P04637 1/20 0.52
CYP2D6 P10635 1/20 0.52
MMP9 P14780 1/20 0.52
ALOX15 P16050 1/20 0.52
NFKB1 P19838 1/20 0.52
MMP8 P22894 1/20 0.52
THPO P40225 1/20 0.52
MTOR P42345 1/20 0.52
HTT P42858 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28548944 0.92 LMNA (0.59) LMNACCR1CCR5CCR8KDM4E
SCHEMBL30074407 0.92 LMNA (0.59) LMNACCR1CCR5CCR8KDM4E
SCHEMBL27885494 0.81 LMNA (0.96) LMNACCR1CCR5CCR8KDM4E
SCHEMBL30432091 0.81 EGFR (0.47) LMNAEGFRPIK3CDPIK3CA
SCHEMBL1096307 0.81 EGFR (0.47) LMNAEGFRPIK3CDPIK3CA
SCHEMBL8313 0.79 LMNA (1.00) LMNACCR1CCR5CCR8KDM4E
SCHEMBL6513577 0.79 LMNA (1.00) LMNACCR1CCR5CCR8KDM4E
SCHEMBL346255 0.79 LMNA (0.65) LMNACCR1CCR5CCR8KDM4E
Pyrazine SCHEMBL28719971 0.78 LMNA (0.89) LMNACCR1CCR5CCR8KDM4E
Cyanide SCHEMBL27465941 0.78 LMNA (0.89) LMNACCR1CCR5CCR8KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119019390-A Method for preparing drug intermediate pyrimido [4,5-b ] quinoline derivative by eutectic solvent catalysis 南京苏亦欣医药科技有限公司 2024-11-26 CN disclosed
CN-116535405-B Benzimidazole fused pyrimidoquinoline fluorescent molecule, and preparation method and application thereof 武汉轻工大学 2024-05-17 CN disclosed
CN-116535405-B Benzimidazole fused pyrimidoquinoline fluorescent molecule, and preparation method and application thereof 武汉轻工大学 2024-05-17 CN disclosed
CN-116535405-B Benzimidazole fused pyrimidoquinoline fluorescent molecule, and preparation method and application thereof 武汉轻工大学 2024-05-17 CN disclosed
CN-116535405-A Benzimidazole fused pyrimidoquinoline fluorescent molecule, and preparation method and application thereof 武汉轻工大学 2023-08-04 CN disclosed
CN-116535405-A Benzimidazole fused pyrimidoquinoline fluorescent molecule, and preparation method and application thereof 武汉轻工大学 2023-08-04 CN disclosed
US-20230151020-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-05-18 US disclosed
US-20230151020-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-05-18 US disclosed
CN-113185512-B 5-aminopyrimido [4,5-b ] quinoline compound and preparation method and application thereof 桂林医学院 2023-05-05 CN disclosed
CN-113185512-A 5-aminopyrimidino [4,5-b ] quinoline compound and preparation method and application thereof 桂林医学院 2021-07-30 CN disclosed
US-9947877-B2 Organic light emitting display device LG DISPLAY CO., LTD. (KR) 2018-04-17 US disclosed
US-9947877-B2 Organic light emitting display device LG DISPLAY CO., LTD. (KR) 2018-04-17 US disclosed
US-20160285010-A1 ORGANIC LIGHT EMITTING DISPLAY DEVICE LG DISPLAY CO., LTD. (KR) 2016-09-29 US disclosed
US-5070086-A ANTIALLERGY, ANTIINFLAMMATORY, ANTIPSORIASIS SCHERING CORPORATION (US) 1991-12-03 US disclosed
US-5070086-A ANTIALLERGY, ANTIINFLAMMATORY, ANTIPSORIASIS SCHERING CORPORATION (US) 1991-12-03 US disclosed
US-5070086-A ANTIALLERGY, ANTIINFLAMMATORY, ANTIPSORIASIS SCHERING CORPORATION (US) 1991-12-03 US disclosed
EP-0325048-A1 Imidazo- and pyrimido-quinoline, naphthyridine and pyridopyrazine compounds SCHERING CORPORATION (US) 1989-07-26 EP disclosed
EP-0325048-A1 Imidazo- and pyrimido-quinoline, naphthyridine and pyridopyrazine compounds SCHERING CORPORATION (US) 1989-07-26 EP disclosed
US-4539230-A COATING WALLS WITH A CHELATE COMPOUND SHIN-ETSU CHEMICAL CO., LTD. (JP) 1985-09-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230151020-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE OCIAD1, OCIAD2, EHD1 LMNA 1600/4885CCR1 3282/4885CCR5 3528/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.